Contents

Current Cancer Drug Targets, Volume 6 - Number 7

TGF Beta Inhibition for Cancer Therapy

, 6(7): 565 - 578

Elise F. Saunier and Rosemary J. Akhurst


DOI: 10.2174/156800906778742460




Simultaneous Amplification of HER-2 (ERBB2) and Topoisomerase IIα (TOP2A) Genes - Molecular Basis for Combination Chemotherapy in Cancer

, 6(7): 579 - 602

Tero A.H. Jarvinen and Edison T. Liu


DOI: 10.2174/156800906778742497




Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models

, 6(7): 603 - 612

J. G. Hengstler, E. O. Bockamp, M. Hermes, M. Brulport, A. Bauer, W. Schormann, I. B. Schiffer, C. Hausherr, L. Eshkind, C. Antunes, A. Franzen, K. Krishnamurthi, E. Lausch, R. Lessig/snm, >, T. Chakrabarti, D. Prawitt, B. Zabel and C. Spangenberg


DOI: 10.2174/156800906778742488




Five-Lipoxygenase Pathway of Arachidonic Acid Metabolism in Carcinogenesis and Cancer Chemoprevention

, 6(7): 613 - 622

Xiaoxin Chen, Sandeep Sood, Chung S. Yang, Ning Li and Zheng Sun


DOI: 10.2174/156800906778742451




Protein Kinases as Drug Targets in Cancer

, 6(7): 623 - 634

Mehmet Alper Arslan, Ozgur Kutuk and Huveyda Basaga


DOI: 10.2174/156800906778742479




Adrenomedullin: A Tumor Progression Factor via Angiogenic Control

, 6(7): 635 - 643

Misa Nakamura, Bo Han, Osamu Nunobiki and Kennichi Kakudo


DOI: 10.2174/156800906778742442




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science